226 related articles for article (PubMed ID: 31006589)
81. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
[TBL] [Abstract][Full Text] [Related]
82. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
[TBL] [Abstract][Full Text] [Related]
83. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
[TBL] [Abstract][Full Text] [Related]
84. Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.
Habr-Gama A; São Julião GP; Gama-Rodrigues J; Vailati BB; Ortega C; Fernandez LM; Araújo SEA; Perez RO
Dis Colon Rectum; 2017 Jun; 60(6):586-594. PubMed ID: 28481852
[TBL] [Abstract][Full Text] [Related]
85. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
Hughes R; Harrison M; Glynne-Jones R
Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
[TBL] [Abstract][Full Text] [Related]
86. Prediction of Pathological Complete Response Using Endoscopic Findings and Outcomes of Patients Who Underwent Watchful Waiting After Chemoradiotherapy for Rectal Cancer.
Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Fukayama M; Watanabe T
Dis Colon Rectum; 2017 Apr; 60(4):368-375. PubMed ID: 28267003
[TBL] [Abstract][Full Text] [Related]
87. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
[TBL] [Abstract][Full Text] [Related]
88. [Guiding significance of pathological diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
Li ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):248-251. PubMed ID: 32192303
[TBL] [Abstract][Full Text] [Related]
89. Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
Temmink SJD; Peeters KCMJ; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Melenhorst J; Burger JWA; Wolthuis A; Renehan AG; Figueiredo NL; Pares O; Martling A; Perez RO; Beets GL; van de Velde CJH; Nilsson PJ;
Br J Surg; 2023 May; 110(6):676-684. PubMed ID: 36972213
[TBL] [Abstract][Full Text] [Related]
90. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
Fan J; Zhu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
[TBL] [Abstract][Full Text] [Related]
91. Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer.
Gani C; Grosse U; Clasen S; Kirschniak A; Goetz M; Rödel C; Zips D
Strahlenther Onkol; 2018 Nov; 194(11):985-990. PubMed ID: 29987338
[TBL] [Abstract][Full Text] [Related]
92. Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code?
Glynne-Jones R; Hughes R
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):152-160. PubMed ID: 26625960
[TBL] [Abstract][Full Text] [Related]
93. Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
Kim HJ; Song JH; Ahn HS; Choi BH; Jeong H; Choi HS; Lee YH; Kang KM; Jeong BK
Int J Colorectal Dis; 2017 May; 32(5):723-727. PubMed ID: 27885479
[TBL] [Abstract][Full Text] [Related]
94. The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery.
Balyasnikova S; Read J; Tait D; Wotherspoon A; Swift I; Cunningham D; Tekkis P; Brown G
Colorectal Dis; 2017 Feb; 19(2):139-147. PubMed ID: 27474876
[TBL] [Abstract][Full Text] [Related]
95. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
[TBL] [Abstract][Full Text] [Related]
96. Watch and wait: Why, to whom and how.
Cerdán-Santacruz C; Vailati BB; São Julião GP; Habr-Gama A; Perez RO
Surg Oncol; 2022 Aug; 43():101774. PubMed ID: 35491334
[TBL] [Abstract][Full Text] [Related]
97. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.
Latkauskas T; Pauzas H; Gineikiene I; Janciauskiene R; Juozaityte E; Saladzinskas Z; Tamelis A; Pavalkis D
Colorectal Dis; 2012 Mar; 14(3):294-8. PubMed ID: 21899712
[TBL] [Abstract][Full Text] [Related]
98. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
[TBL] [Abstract][Full Text] [Related]
99. Cost analysis of a watch-and-wait approach in patients with a complete clinical response to chemoradiotherapy for rectal cancer.
Cooper EA; Hodder RJ; Finlayson A; Filgate R; Coveney A; Balasuriya HD; Warner MW
ANZ J Surg; 2022 Nov; 92(11):2956-2960. PubMed ID: 35855528
[TBL] [Abstract][Full Text] [Related]
100. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
